Vorinostat

Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis[1][4]. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV) -18 DNA amplification[7].

Product Specifications

CAS Number

[149647-78-9]

Product Name Alternative

SAHA; Suberoylanilide hydroxamic acid

UNSPSC

12352005

Hazard Statement

H341, H360

Target

Apoptosis; Autophagy; Filovirus; HDAC; HPV; Mitophagy

Type

Reference compound

Related Pathways

Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/Vorinostat.html

Purity

99.96

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C(NC1=CC=CC=C1)CCCCCCC(NO)=O

Molecular Formula

C14H20N2O3

Molecular Weight

264.32

Precautions

H341, H360

References & Citations

[1]Hrzenjak A et al. Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. Mol Cancer. 2010 Mar 4;9:49.|[2]Lautz TB, et al. The effect of vorinostat on the development of resistance to NSC 123127 in neuroblastoma. PLoS One. 2012;7 (7) :e40816.|[3]Richon VM, et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A. 1998 Mar 17;95 (6) :3003-7.|[4]Xu WS, et al. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007 Aug 13;26 (37) :5541-52.|[5]Pérez-Cañamás A, et al. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease. Mol Psychiatry. 2017 May;22 (5) :711-723.|[6]Wang J, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017 Dec 20;8 (1) :2207.|[7]Banerjee NS, et al. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification. Proc Natl Acad Sci U S A. 2018 Nov 20;115 (47) :E11138-E11147.